P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE

• M. J. van Dijk,
• M. A. Rab,
• B. A. van Oirschot,
• J. Bos,
• C. Derichs,
• A. W. Rijneveld,
• M. H. Cnossen,
• E. Nur,
• B. J. Biemond,
• M. Bartels,
• J. J. Jans,
• W. W. van Solinge,
• R. E. Schutgens,
• R. van Wijk,
• E. J. van Beers

Affiliations

M. J. van Dijk

1 University Medical Center Utrecht, Utrecht

M. A. Rab

1 University Medical Center Utrecht, Utrecht

B. A. van Oirschot

1 University Medical Center Utrecht, Utrecht

J. Bos

1 University Medical Center Utrecht, Utrecht

C. Derichs

1 University Medical Center Utrecht, Utrecht

A. W. Rijneveld

2 Erasmus University Medical Center, Rotterdam

M. H. Cnossen

2 Erasmus University Medical Center, Rotterdam

E. Nur

3 Amsterdam University Medical Center

B. J. Biemond

3 Amsterdam University Medical Center

M. Bartels

1 University Medical Center Utrecht, Utrecht

J. J. Jans

1 University Medical Center Utrecht, Utrecht

W. W. van Solinge

1 University Medical Center Utrecht, Utrecht

R. E. Schutgens

1 University Medical Center Utrecht, Utrecht

R. van Wijk

1 University Medical Center Utrecht, Utrecht

E. J. van Beers

1 University Medical Center Utrecht, Utrecht